GlassScriptPhysician profile
Brian C Chado
NPI 1790347904
$2,824.33
in general payments reported to CMS, 2019-2025
19 companies · $514 in 2025
The $514 reported for 2025 was more than what 78% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.67 · 2020: $74.76 · 2021: $601 · 2022: $463 · 2023: $432 · 2024: $652 · 2025: $514.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,598.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,598.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $488.03 | 2020-2025 | Clareon, Precision 1, Tryptyr |
| Bausch & Lomb Americas INC. | $403.44 | 2022-2025 | Miebo, Infuse, Biotrue One Day |
| Allergan, INC. | $270.63 | 2021-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $257.95 | 2020-2021 | |
| Oyster Point Pharma, INC. | $254.12 | 2022-2025 | Tyrvaya, Ryzumvi |
| Johnson & Johnson Vision Care, INC. | $199.55 | 2020-2025 | Acuvue |
| Coopervision INC. | $143.22 | 2021-2024 | Myday Contact Lens, Clariti Contact Lens |
| Abbvie INC. | $139.25 | 2022-2025 | Durysta |
| Harrow Eye, LLC | $114.44 | 2024-2025 | Vevye, Iheezo |
| Sun Pharmaceutical Industries INC. | $111.17 | 2023-2025 | Cequa |
| Tarsus Pharmaceuticals, INC. | $100.78 | 2024-2025 | Xdemvy |
| Carl Zeiss Meditec, INC. | $86.67 | 2019 | |
| Biotissue Holdings INC. | $65.12 | 2024-2025 | |
| Kala Pharmaceuticals, INC. | $61.00 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $53.17 | 2021-2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $27.11 | 2024 | Ce-Marked Kxla System |
| Dompe US, INC. | $23.54 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $13.71 | 2024 | Amo Phaco Needle |
| Oasis Medical, INC. | $11.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Chado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.